Aeglea Biotherapeutics Inc.
13F holders, Q1 2024 (March 31)1holders
$22.32avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Aeglea Biotherapeutics Inc. in their 13F filings. The largest holder was Yu Fan ($16.4M).
- Company
- Aeglea Biotherapeutics Inc.
- Filed as
- CASTLE BIOSCIENCES INC (Q1 2024)
- CUSIP
- 00773J103
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $16.4M |
| Exits | 0 | $0 |
Ownership 1 holders
| Yu Fan | 22.68% | New | 737,000 | $16.4M |
"% of holder's portfolio" is AEGLEA BIOTHERAPEUTICS INC's weight in each manager's 13F, not the share of Aeglea Biotherapeutics Inc. the manager owns.